Vanguard Personalized Indexing Management LLC Purchases 6,672 Shares of Cigna Group $CI

Vanguard Personalized Indexing Management LLC lifted its position in Cigna Group (NYSE:CI) by 17.0% during the 2nd quarter, Holdings Channel reports. The firm owned 45,805 shares of the health services provider’s stock after acquiring an additional 6,672 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Cigna Group were worth $15,159,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in CI. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Cigna Group by 79.0% in the first quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock worth $1,775,000 after purchasing an additional 2,381 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Cigna Group by 3.4% in the first quarter. Fifth Third Bancorp now owns 26,314 shares of the health services provider’s stock worth $8,657,000 after purchasing an additional 874 shares during the last quarter. Thomasville National Bank bought a new position in shares of Cigna Group in the first quarter worth approximately $201,000. Finally, NorthCrest Asset Manangement LLC grew its holdings in shares of Cigna Group by 14.6% in the first quarter. NorthCrest Asset Manangement LLC now owns 11,327 shares of the health services provider’s stock worth $3,727,000 after purchasing an additional 1,446 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $301.00 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $80.35 billion, a P/E ratio of 16.43, a P/E/G ratio of 0.88 and a beta of 0.45. The business has a fifty day simple moving average of $294.68 and a two-hundred day simple moving average of $309.23. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is currently 32.97%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CI shares. Robert W. Baird set a $372.00 target price on shares of Cigna Group in a report on Thursday, August 14th. TD Cowen raised Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Truist Financial set a $375.00 price target on Cigna Group in a research note on Tuesday, September 2nd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Wells Fargo & Company raised their price target on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $372.69.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.